Monthly Archives: August 2020

SphingoTec’s kidney function biomarker penKid® accurately detects acute kidney injury in infants

penKid® (Proenkephalin), a unique biomarker for the real-time assessment of kidney function Novel data now demonstrate that penKid® also accurately predicts acute kidney injury in infants and provides substantial additional value on top of the diagnostic standard of care Hennigsdorf/Berlin, Germany, August 27, 2020 – Diagnostics company SphingoTec GmbH (“SphingoTec”) announced today the publication of…
Read more

SphingoTec Issues Convertible Note Facility

Hennigsdorf, Germany August 19, 2020 – Diagnostic company SphingoTec GmbH (SphingoTec) today announced that the Company has issued a non-brokered, unsecured convertible note facility amounting to EUR 5 million that was fully subscribed by current and new investors. The proceeds of the transaction will bridge to a larger financing round planned for later this year…
Read more

SphingoTec to Present at the Solebury Trout’s Summer Private Company Showcase

Hennigsdorf/Berlin, Germany – August 6, 2020 – Diagnostics company SphingoTec GmbH (“SphingoTec”) today announced that Dr Andreas Bergman, CEO, and Ferdinand Von Humboldt, CFO, will be presenting a corporate overview at the Summer Private Company Showcase, hosted by Solebury Trout on August 10, 2020. SphingoTec develops and markets in-vitro diagnostic tests for novel and proprietary…
Read more

Top